MiNK Therapeutics, Inc. (INKT)
$10.53-1.77%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $52M
- Beta
- 0.47
- P/E (TTM)
- -4.90
- Short % float
- 4.15%
- Days to cover
- 3.1
- SI change
- -13.2%
- 1W
- -13.69%
- 1M
- -12.25%
- vs SPY 1W
- -14.11%
- vs SPY 1M
- -14.31%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on INKT?
- LOPJLB’s latest quantitative signal on MiNK Therapeutics, Inc. (INKT) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is INKT in?
- MiNK Therapeutics, Inc. (INKT) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does MiNK Therapeutics, Inc. (INKT) do?
- MiNK Therapeutics, Inc. is a biopharmaceutical firm currently undergoing clinical trials. Its primary focus is on the identification, advancement, and market introduction of innovative invariant natural killer T (iNKT) cell therapies. These treatments are allogeneic and designed to be "off-the-shelf," providing readily available options for combating various cancers and conditions rooted in imm…